<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04969120</url>
  </required_header>
  <id_info>
    <org_study_id>Metoclopramide and labour</org_study_id>
    <nct_id>NCT04969120</nct_id>
  </id_info>
  <brief_title>Metoclopramide and the Length of First Stage of Labor , a Randomized Controlled Trial</brief_title>
  <official_title>The Effect of Metoclopramide on the Length of First Stage of Labor in Nulliparous Women, a Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cairo University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cairo University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Reducing the length of labor is a highly desirable goal of intrapartum care, both from a&#xD;
      perspective of maternal and fetal well-being and for the providers of the birth services.&#xD;
      Avoiding a long, protracted labor entails shorter exposure to pain anxiety and stress and&#xD;
      would translate into a major improvement in maternal satisfaction with the childbirth&#xD;
      experience.&#xD;
&#xD;
      Prolonged labor can lead to increased maternal and neonatal morbidity and mortality such as&#xD;
      rupture of the uterus, postpartum hemorrhage, puerperal sepsis, and maternal death. Prolonged&#xD;
      labor may be due to maternal age, premature rupture of membrane, epidural analgesia and the&#xD;
      secretion of high levels of maternal stress hormones.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Several studies showed that active management of labor could shorten the duration of labor,&#xD;
      and the safety of this method has been demonstrated.&#xD;
&#xD;
      Metoclopramide binds to dopamine receptors acting as a receptor antagonist, and it is also a&#xD;
      mixed serotonin receptor agonist and antagonist.&#xD;
&#xD;
      Metoclopramide could potentially reduce spasms of the smooth muscle of the cervix that&#xD;
      remains richly innervated at birth and thus have a regulatory effect on cervical&#xD;
      contractility, an interaction that might be important in aiding maximal tissue compliance,&#xD;
      promoting cervical dilatation during labor, and helping to reduce dystocia. Dopamine and&#xD;
      other catecholamines have been identified in rabbit, rat, guinea-pig, sheep, and human uteri.&#xD;
&#xD;
      The purpose of this study is to determine the effectiveness of metoclopramide for reducing&#xD;
      the duration of spontaneous labor among nulliparous women managed according to a standard&#xD;
      intrapartum protocol.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">November 15, 2021</start_date>
  <completion_date type="Anticipated">April 2022</completion_date>
  <primary_completion_date type="Anticipated">April 2022</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>Double (Participant, Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>duration of labour</measure>
    <time_frame>8-12 hours</time_frame>
    <description>cervical dilatation rate in first stage of labour</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>labour pain</measure>
    <time_frame>pain assessment at 30,60,120 minutes following injection of metoclopramide</time_frame>
    <description>effect of metoclopramide on labour pain score using visual analogue scale which is a score from 0 to 10 cm The higher the score represents more pain</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Labour Duration and Metoclopramide</condition>
  <arm_group>
    <arm_group_label>(group 1) receiving intravenous metoclorpramide</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>this group receive 10mg intravenous metoclopramide</description>
  </arm_group>
  <arm_group>
    <arm_group_label>(group 2) receiving placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>this group receive 10mg intravenous placebo(0.9 sodium chloride)</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Metoclopramide 10mg</intervention_name>
    <description>this group receive 10mg intravenous metoclopramide slowly over 2 minutes the medication will be repeated every 2 hours for a maximum three doses</description>
    <arm_group_label>(group 1) receiving intravenous metoclorpramide</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo (0.9 sodium chloride)</intervention_name>
    <description>this group receive 10mg intravenous placebo(0.9 sodium chloride) slowly over 2 minutes the medication will be repeated every 2 hours for a maximum three doses</description>
    <arm_group_label>(group 2) receiving placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  primigravida&#xD;
&#xD;
          -  singleton pregnancy&#xD;
&#xD;
          -  termgestation (37-42 weeks)&#xD;
&#xD;
          -  sure reliable dated&#xD;
&#xD;
          -  vertex presentation , occipito-anterior position&#xD;
&#xD;
          -  regular uterine contractions at every 5 minutes,each lasting for 20 seconds&#xD;
&#xD;
          -  cervical dilatation of 5 cm&#xD;
&#xD;
          -  with or without rupture of membrane&#xD;
&#xD;
          -  no evidence of maternal or fetal distress&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  chorioamnionitis&#xD;
&#xD;
          -  scarred uterus e.g. myomectomy&#xD;
&#xD;
          -  cephalopelvic dispropotion&#xD;
&#xD;
          -  history of cervical surgery or injury&#xD;
&#xD;
          -  hypersensitivity to metoclopramide&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Shaimaa Elshemy, MD</last_name>
    <phone>01220632263</phone>
    <email>sh.elshemy@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Khaled Elsetohoy</last_name>
    <phone>+20 111 000 6946</phone>
    <email>kelsetohy@kasralainy.edu.eg</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Obstetrics and gynecology department at kasralainy hospital</name>
      <address>
        <city>Cairo</city>
        <zip>11562</zip>
        <country>Egypt</country>
      </address>
    </facility>
    <contact>
      <last_name>Obstetrics and gynecology department Kasralainy hospital</last_name>
      <phone>02-23632453</phone>
      <email>Info@egepure.org</email>
    </contact>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>June 27, 2021</study_first_submitted>
  <study_first_submitted_qc>July 9, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">July 20, 2021</study_first_posted>
  <last_update_submitted>October 28, 2021</last_update_submitted>
  <last_update_submitted_qc>October 28, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 1, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Cairo University</investigator_affiliation>
    <investigator_full_name>Shaimaa Mostafa Mohammed Refaay El shemy</investigator_full_name>
    <investigator_title>Lecturer of Obstetrics and gynecology at Cairo university</investigator_title>
  </responsible_party>
  <keyword>Metoclopramide - labor duration-labor pain</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Metoclopramide</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

